Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Down‐titration and Discontinuation Strategies of Tumour Necrosis Factor–blocking Agents for Rheumatoid Arthritis in Patients With Low Disease Activity." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436477/2/Down‐titration_and_discontinuation_strategies_of_tumour_necrosis_factor–blocking_agents_for_rheumatoid_arthritis_in_patients_with_low_disease_activity. Accessed 03 November 2024.
Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436477/2/Down‐titration_and_discontinuation_strategies_of_tumour_necrosis_factor–blocking_agents_for_rheumatoid_arthritis_in_patients_with_low_disease_activity. Accessed November 3, 2024.
Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436477/2/Down‐titration_and_discontinuation_strategies_of_tumour_necrosis_factor–blocking_agents_for_rheumatoid_arthritis_in_patients_with_low_disease_activity
Down‐titration and Discontinuation Strategies of Tumour Necrosis Factor–blocking Agents for Rheumatoid Arthritis in Patients With Low Disease Activity [Internet]. In: Cochrane Abstracts. [cited 2024 November 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436477/2/Down‐titration_and_discontinuation_strategies_of_tumour_necrosis_factor–blocking_agents_for_rheumatoid_arthritis_in_patients_with_low_disease_activity.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity
ID - 436477
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436477/2/Down‐titration_and_discontinuation_strategies_of_tumour_necrosis_factor–blocking_agents_for_rheumatoid_arthritis_in_patients_with_low_disease_activity
DB - Evidence Central
DP - Unbound Medicine
ER -